Jeffrey Sosman Archive — Page 1 of 2
-
March 28, 2013
Foundation lauds graduate student’s melanoma research
Katherine Hutchinson, a third-year graduate student in Cancer Biology at Vanderbilt University, has won a $10,000 Research Scholar Award from the Joanna M. Nicolay Melanoma Foundation. -
October 25, 2012
Combined drug therapy may delay melanoma progression
Combination therapy with two drugs delayed the development of treatment resistance in patients with metastatic melanoma that expresses a specific mutation in the BRAF gene. -
August 30, 2012
Stand Up to Cancer TV broadcast airs Sept. 7
-
July 26, 2012
Study finds mutation in melanoma sensitive to drug
An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. -
July 12, 2012
New cancer drug shows promise in early testing
-
January 26, 2012
Investigators seek clues to resistance to melanoma drug
Investigators at Vanderbilt-Ingram Cancer Center and several other centers may be one step closer to finding out why some melanoma patients relapse after treatment with a promising new drug. -
January 5, 2012
Sosman named to ‘Dream Team’ of cancer investigators